Effectiveness and safety of secukinumab in Chinese patients with plaque psoriasis in a clinical practice setting: a pilot study.

Chin Med J (Engl) · 2020 · PMC7752686 · PMID 33337762

Europe PMC DOI

hedged sentence

0.0960

closest p · 1.9× alpha

0.0960

boldest claim

The sentences

did not reach statistical significanceP = 0.096so close (0.05 < p ≤ 0.1)

BSA slightly improved at week 2 but did not reach statistical significance ( Z week 2 = −1.663, P = 0.096); however, at weeks 4 and 12, BSA was significantly reduced compared with the baseline BSA of 20.3% (7.6–31.3%) ( Z week 4 = −2.810, P = 0.005; Z week 12 = −3.408, P = 0.001).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.